Results 51 to 60 of about 1,242,031 (332)
Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19. [PDF]
, 2020 BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a novel beta-coronavirus that has recently emerged as the cause of the 2019 coronavirus pandemic (COVID-19).
Fitzgerald, Robert L +5 more
core
Guillain‐Barré syndrome after SARS‐CoV‐2 infection
Journal of General and Family Medicine, 2022 We herein report a case of Guillain‐Barré syndrome (GBS) after SARS‐CoV‐2 infection. The patient was a close contact with a SARS‐CoV‐2 patient. Initially, she did not have any symptoms and quarantined at a hotel.
Mikiya Kajita +5 more
doaj +1 more source
Science, 2020 Targeting a key enzyme in SARS-CoV-2 Scientists across the world are working to understand severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). Zhang et al.
Linlin Zhang +8 more
semanticscholar +1 more source
Investigating the Dark Figure of COVID-19 Cases in Austria: Borrowing From the Decode Genetics Study in Iceland [PDF]
, 2020 The number of undetected cases of SARS-CoV-2 infections is expected to be a multiple of the reported figures mainly due to the assumed high proportion of asymptomatic infections and to limited availability of trustworthy testing resources. Relying on the
Hirk, Rainer +2 more
core +1 more source
Therapeutic antibodies under development for SARS‐CoV‐2
View, 2022 The world is experiencing one of the most difficult moments in history with COVID‐19, which has rapidly developed into a worldwide pandemic with a significant health and economic burden.
Zetong Ma +7 more
doaj +1 more source
Pathophysiology, histopathology and therapeutic of SARS-CoV-2 [PDF]
, 2020 The rapid transmission of SARS-CoV-2 through the world has induced the scientist to understand the histopathology of the virus and then to find an effective drug.
Al-Gheethi, Adel +6 more
core
Erythema Multiforme Major following SARS‐CoV‐2 vaccine
Clinical Case Reports, 2021 Erythema multiforme major, an immune‐mediated skin reaction to infections or medications with oral involvement, should be taken into account as a potential side effect of several vaccines, including SARS‐CoV‐2.
Alberto Maria Saibene +7 more
doaj +1 more source
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Nature Microbiology, 2020 The ongoing pandemic spread of a new human coronavirus, SARS-CoV-2, which is associated with severe pneumonia/disease (COVID-19), has resulted in the generation of tens of thousands of virus genome sequences.
A. Rambaut +7 more
semanticscholar +1 more source
A brief overview of current drug repurposing approaches for COVID-19 management [PDF]
, 2020 This brief overview is intended to shed light on the current drug repositioning (also called drug repurposing) in the therapeutics of the novel coronavirus disease which emerged in 2019 (COVID-19).
Rodrigues, Pedro da Fonseca Soares +1 more
core +2 more sources
SARS‐CoV‐2 infection with bilateral intralabyrinthine hemorrhage
Clinical Case Reports, 2022 A 47‐year‐old woman presented with the complaint of sudden hearing loss associated with vertigo. Serological testing was positive for IgM and negative for IgG COVID‐19 antibodies, with no other associated factors.
Vagner Antonio Rodrigues daSilva +6 more
doaj +1 more source